Botulinum type A treatment of depressive episode in bipolar patients

Phase 2

• Conditions: Bipolar II disorder.; Bipolar II disorder; F31.81

• Registration Number: IRCT20160523028008N7
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients with diagnosed bipolar depression based on DSM-5
MADRS score equal to or more than 7

Exclusion Criteria

History of Botox injections in the past year.
Contraindication to receiving botulinum type A.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression rate. Timepoint: At the start of intervention- After intervention. Method of measurement: Hamilton Scale.